Plain-English translation of NCT07802561 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
Pakistan
Phase
Post-approval monitoring
Sponsor
Nishtar Medical University
Enrollment target
~92 participants
Started
April 2026
Primary completion
October 2026
Age range
18 Years – 45 Years
Sex
Female only
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Iqra M Principal Investigator, MBBS
Nishtar Medical University and Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.